Skip to main content

Table 1 Patient Demographics

From: The clinical relevance of luteal phase progesterone support in true natural cycle cryopreserved blastocyst stage embryo transfers: a retrospective cohort study

  Progesterone (n = 149 [65%]) No Progesterone (n = 80 [35%])
Age of women producing oocytes (years) 34.2 (3.9) 35.6 (3.1)
BMI at egg retrieval (kg/m2) 24.6 (6.1) 25.1 (6.8)
Gravity 1.4 (1.6) 1.2 (1.5)
Parous Y/N 48 (32.2%) 32 (40.0%)
Infertility Diagnosis n (%)  
DOR 26 (17.5%) 6 (7.5%)
 Unexplained 59 (39.6%) 33 (41.3%)
 Uterine factor 8 (5.4%) 4 (5.0%)
 Anovulatory 10 (6.7%) 3 (3.8%)
 Endometriosis 9 (6.0%) 6 (7.5%)
 Tubal Factor 17 (11.4%) 6 (7.5%)
 Male Factor 32 (21.5%) 24 (30.0%)
AMH at start of retrieval cycle 3.4 (3.1) (n = 131) 4.1 (3.7) (n = 73)
Race/ethnicity of recipient n (%)  
Caucasian or White 115 (77.2%) 55 (68.8%)
Black or African American 6 (4.0%) 3 (3.8%)
Hispanic or Latino/a 0 1 (1.3%)
American Indian or Alaska Native 1 (0.7%) 0
Asian 23 (15.4%) 19 (23.8%)
Other/Unknown 4 (2.7%) 2 (3.0%)
Average number of prior transfers at BWH 3.2 (3.0) 3.0 (3.4)
No prior transfers at BWH 14 (9.4%) 5 (6.3%)
  1. Values are mean (SD)
  2. AMH Antimullerian hormone, BWH Brigham and Women’s Hospital
  3. Infertility diagnoses add up to more than 100% as some patients have multiple diagnoses and each was included in the analysis